Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis

Letter/Communication

T D Polk, S R Russell, K M Gehrs and J C Folk

Retina (Philadelphia, Pa.), Vol.17(5), pp.463-464

1997

PMID: 9355202

View Online

Drug Implants

Cytomegalovirus Retinitis - drug therapy

Antiviral Agents - administration & dosage

Delayed-Action Preparations

Humans

Ganciclovir - administration & dosage

Title: Subtitle: Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis
Creators: T D Polk
S R Russell
K M Gehrs
J C Folk
Resource Type: Letter/Communication
Publication Details: Retina (Philadelphia, Pa.), Vol.17(5), pp.463-464
Publisher: United States
PMID: 9355202
ISSN: 0275-004X
eISSN: 1539-2864
Language: English
Date published: 1997
Academic Unit: Ophthalmology and Visual Sciences
Record Identifier: 9983979982402771

15 Record Views